Home-Based COVID-19 Diagnostic Techniques Under Development
Breaking News:
Get ready for the first home COVID-19 test that promises results in 15 minutes! American innovators have crafted this brilliant invention, as reported by Almaty.tv, citing Rambler.
To test if COVID-19 lurks in your system, you'll need a simple nose swab using a cotton swab. Pop it into a special bottle filled with buffer solution, and then drop a bit of the mix onto the test cassette. If the virus is there, the cassette will let you know.
"A swift, reliable, budget-friendly, and user-friendly at-home antigen test will significantly slash virus transmission, particularly among asymptomatic individuals," the developers passionately claim on their website.
But here's the catch: you can't buy it yet. The developers still need the green light from the U.S. Food and Drug Administration (FDA).
Some facts about the FDA's ongoing authorization process for home COVID-19 tests:- Existing approved tests: Multiple over-the-counter (OTC) COVID-19 tests are already playing ball with the FDA's Emergency Use Authorization (EUA), such as the iHealth COVID-19 Antigen Rapid Test.- Review focus: The FDA is currently concentrating on evaluating if COVID-19 products (including tests and vaccines) offer tangible benefits given our current immunity levels.- Near-future pipeline: As of May 2025, a "next-gen COVID-19 vaccine" is under review, but concrete timelines for new at-home test approvals remain under wraps.
Since the specific companies remain undisclosed, it's unclear if their tests are under active review. Developers must offer evidence for EUA consideration, and approvals hinge on the evidence's completeness and the FDA's priority level. If you're eager for immediate options, you can check out the FDA's list of authorized tests for up-to-date expiration dates and instructions [1].
As for the new kid on the block, the process generally goes like this:1. Submit performance data to the FDA2. Undergo FDA review under EUA criteria3. Secure public authorization if benefits outweigh risks
As of April 2025, no recent announcements hint at imminent approvals for unnamed home tests. Stay tuned!
[1] FDA's list of authorized COVID-19 tests: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/categories-authorization-coronavirus-diagnostic-tests[2] iHealth COVID-19 Antigen Rapid Test: https://www.itest.com/products/ihealth-covid-19-antigen-rapid-test-2-pack[3] Recent FDA communications: https://www.fda.gov/news-events/public-health-focus/assessing-benefits-risks-covid-19-vaccines-children-and-adolescents[4] Next-gen COVID-19 vaccine in review as of May 2025: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/coronavirus-disease-2019-covid-19-vaccines-euas-paused-or-revoked
- While the upcoming home COVID-19 test holds promise for rapid results, it is not yet available to the public due to the U.S. Food and Drug Administration (FDA)'s ongoing review process.
- Health experts including those in Almaty, science, and medical-conditions are eager for the release of this test, believing it could help in early detection of the virus, especially among asymptomatic individuals.
- Artificial Intelligence and technology may play a role in the FDA's evaluation of the home COVID-19 tests, ensuring swift and accurate authorization decisions.
- The FDA has already authorized over-the-counter (OTC) COVID-19 tests such as the iHealth COVID-19 Antigen Rapid Test, and continues to prioritize the evaluation of existing and upcoming tests based on their potential benefits and the current state of immunity levels.
- To keep up-to-date on the latest developments in home COVID-19 tests, it is recommended to visit the FDA's website for a current list of authorized tests and their expiration dates.
